NCM · Financial Statements

Starling Oncology, Inc. (STLN) Financial Statements

$6.63 NCM: STLN Market Cap $662.89M

Starling Oncology, Inc. most recently reported annual revenue of $503.0M, net profit of $-61.0M, revenue has compounded at 21.8% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$203.0M$252.0M$324.0M$393.0M$503.0M
Operating Profit$-46.0M$-82.0M$-77.0M$-60.0M$-36.0M
Net Profit$-11.0M$0$-83.0M$-65.0M$-61.0M
EPS$-0.16$-0.21$-0.92$-0.71$-0.54
Op Margin-23.0%-32.0%-24.0%-15.0%-7.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$203.0M$262.0M$209.0M$173.0M$165.0M
Total Liabilities$99.0M$138.0M$152.0M$169.0M$180.0M
Cash$1.0M$1.0M$1.0M$1.0M$1.0M
Borrowings$0$81.0M$87.0M$93.0M$78.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-33.0M$-62.0M$-36.0M$-27.0M$-25.0M
Investing Cash Flow$-12.0M$-132.0M$63.0M$46.0M$-3.0M
Financing Cash Flow$154.0M$92.0M$-7.0M$-3.0M$12.0M
Net Cash Flow$109.0M$-101.0M$19.0M$16.0M$-16.0M
Free Cash Flow$-36.0M$-67.0M$-41.0M$-30.0M$-28.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.31
EV / EBITDA-31.49
FCF Yield-0.53%
Quick Ratio1.15
Interest Coverage-3.42
Return 1Y46.11%
Return 3Y538.66%
Return 5Y-37.61%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
STLN Overview STLN Dividend Run Stock Screener